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Abstract
The non-medical use of prescription pain relievers has increased remarkably, posing
social and public health concerns particularly in developed countries such as the United
States. The management of pain experienced by pregnant women poses a challenge to
clinicians considering the effects of the regimen on unborn babies. Guided by the health
belief model, which aims to predict health-related behavior in terms of certain health
beliefs and explain change and behavior maintenance as well as to guide health behavior
interventions, this cross-sectional study aimed to understand the associations between
misusing pain relievers and social determinants of health such as education level and race
in pregnant women done using secondary analysis of data from a countrywide survey,
National Survey on Drug Use and Health of 2016. These variables were dichotomized
before running the binary logistic regression. A final study sample of 732 pregnant
women were included, and 11.5% misused prescription pain relievers. Over 85% were
non-African-American with most aged between 18 and 44, and over 82% had a high
school diploma and above. Hydrocodone was the most misused prescription pain reliever.
The regression showed that African-American women have a lower probability of
misusing prescription pain relievers (Exp.(B) 0.06). Targeted interventions will use this
data to address this public health concern among pregnant women therefore aiming to
achieve Healthy People 2030 resulting in positive social change.

Misuse of Prescription Pain Relievers Among Pregnant Women in The United States
by
Winnie C. Rono

Doctoral Study Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Public Health

Walden University
June 2021

Dedication
To my family. You all stood by me during this doctoral journey. You are my
inspiration.

Acknowledgments
It is indeed with a great sense of fulfillment and humility that I acknowledge Dr.
Jennifer Edwards for her commitment and constant dialogue. As the chair of my doctoral
committee, her enormous support in achieving my objectives deserves credit and
gratitude.
Sincere gratitude is given to the other members of my doctoral committee for
their tireless efforts to take me through the whole process of premise development to the
write-up of this final study throughout the academic years. I am indebted to Dr. Cornelia
White, who offered detailed and insightful feedback that guided me in my study. Dr.
Patrick Dunn deserves gratitude for his expertise and for connecting me to useful
resources. Dr. Bill Davis was a member whose invaluable input especially in the
scholarly writing skills is greatly appreciated.
Special mention is made to the various authors whose writings inspired me to do
this study and have been a constant reference point in my work.
Last but not least, I would like to thank my family for their constant support
technically, financially, and emotionally. Their role in the production of this study will
forever be cherished.
It is your support, co-operation, and constant dialogue that led to my success. I
hope and trust that you all share with me the joy of the success of my doctorate.

Table of Contents
List of Tables ..................................................................................................................... iv
List of Figures ......................................................................................................................v
Section 1: Foundation of the Study and Literature Review .................................................1
Foundation of the Study .................................................................................................1
Statement of the Problem ...............................................................................................4
Specific Purpose of the Study ........................................................................................5
Research Questions and Hypotheses .............................................................................7
Operational Definition of Terms ....................................................................................7
Nature of the Study ........................................................................................................8
Literature Review...........................................................................................................9
Literature Search Strategy....................................................................................... 9
Key Search Terms ................................................................................................... 9
Theoretical Framework ........................................................................................... 9
Constructs of HBM and Misuse of Painkillers ..................................................... 11
Misuse of Painkillers............................................................................................. 14
Policies and Programs ........................................................................................... 17
Social Change ....................................................................................................... 18
Summary ......................................................................................................................22
Section 2: Research Design and Data Collection ..............................................................23
Introduction ..................................................................................................................23
Target Population .........................................................................................................24
i

Sampling Procedures and Sample Size Determination ................................................25
Inclusion and Exclusion Criteria ..................................................................................25
Power Analysis for Sample Size Determination ..........................................................26
Datasets and Variables .................................................................................................27
Research Questions ......................................................................................................27
Analytical Strategies ....................................................................................................28
Threats to Validity .......................................................................................................30
Internal Validity .................................................................................................... 31
External Validity ................................................................................................... 32
Ethical Considerations .................................................................................................32
Summary ......................................................................................................................33
Section 3: Presentation of the Results and Findings ..........................................................35
Introduction ..................................................................................................................35
Descriptive Demographics of the Sample............................................................. 36
Summary ......................................................................................................................46
Section 4: Application to Professional Practice and Implications for Social
Change ...................................................................................................................48
Introduction ..................................................................................................................48
Interpretation of Findings ............................................................................................48
Limitations of the Study...............................................................................................50
Recommendations ........................................................................................................51
Implications for Professional Practice and Social Change ..........................................52
ii

Conclusion ...................................................................................................................54
References ..........................................................................................................................56
Appendix ............................................................................................................................68

iii

List of Tables
Table 1. Distribution of Pregnant Women According to Misuse vs. Non-Misuse of
Prescription Pain Relievers ........................................................................................36
Table 2. Distribution of Pregnant Women According to Age ...........................................37
Table 3. Distribution of Pregnant Women According to Race ..........................................38
Table 4. Crosstabulation of Race and Pain Reliever Misuse .............................................38
Table 5. Distribution of Pregnant Women According to Education Level........................38
Table 6. Crosstabulation of Education Level and Pain Relieve Misuse ............................39
Table 7. Last Pain Reliever Used by Pregnant Women Not Directed by the Doctor in the
Past 12 Months ...........................................................................................................39
Table 8. Omnibus Tests of Model Coefficients .................................................................40
Table 9. Model Summary ..................................................................................................41
Table 10. Hosmer and Lemeshow Test..............................................................................41
Table 11. Contingency Table for Hosmer and Lemeshow Test ........................................41
Table 12. Specificity and Sensitivity of the Model............................................................42
Table 13. Binary Logistic Regression ................................................................................44
Table 14. Summary of Findings.........................................................................................46
Table 15. Summary of Results by Research Question and Predictor ................................48

iv

List of Figures
Figure 1. Diagrammatic Presentation of HBM ................................................................. 10
Figure 2. Distribution of Pregant Women According to Age ........................................... 37

v

1
Section 1: Foundation of the Study and Literature Review
Foundation of the Study

Misuse of Prescription Pain Relievers
The magnitude of the burden of pain especially noncancer pain is poorly
measured as stated by Bonnie et al. (2019). With the emerging attention of pain and its
undertreatment, pain relievers have been prescribed to alleviate this, leading to an
increase in the prescriptions (Maxwell, 2011). Marijuana is the leading illicit drug used in
the United States, followed by the misuse of prescription pain relievers such as Vicodin,
OxyContin, and methadone, as stated by Lipari and Hughes (2017). Lipari and Hughes
also stated that despite the decline in the rate of opioid misuse, the number of deaths
following overdoses and admissions due to substance use has increased. Bonnie et al.
(2019) stated that the opioid epidemic lies at an intersection between two public health
challenges: reducing the suffering from the burden of pain and containing the
consequences of opioid use.
The non-medical use of prescription pain relievers has increased remarkably,
posing both social and public health concerns, particularly in developed countries such as
the United States. Most people are unaware they have this problem hence may not seek
treatment. An estimated 22 million Americans in 2005 struggled with drug or alcohol
problems, and the consequences of this have affected the quality of life for millions of
individuals, families, and communities across the world (Sung et al., 2005). According to
Substance Abuse and Mental Health Services Administration ([SAMHSA], 2019),
alcohol is the third leading cause of preventable deaths among Americans with 88,000
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approximate deaths annually. The SAMHSA reported an estimated 2.1 million people
aged 12 and above having an opioid use disorder. Injury or death from accidents, poor
school performance, and poor judgment and decision making are some consequences of
underage drinking and substance abuse (SAMHSA, 2019). Teen pregnancy, sexually
transmitted diseases such as human immunodeficiency virus (HIV), child abuse, and
domestic violence are among other consequences of these habits as listed by the Office of
Disease Prevention and Health Promotion (n.d.).
Maxwell (2011) associated this increasing trend to factors such as aggressive
marketing strategies by pharmaceutical companies, an increase in the prescriptions for
such drugs, availability of the pain relievers both legally and illegally, and inappropriate
or incorrect prescriptions by untrained physicians. Centers for Disease Control and
Prevention [CDC] (2014b) lists Vicodin (hydrocodone + acetaminophen), OxyContin
(oxycodone), and methadone as prescription opioids that can be used for pain
management. According to the CDC (2018), over 191 million opioid prescriptions were
dispensed to Americans across the nation in 2017 with more than 11.5 million people
reporting misusing them in the past 1 year in 2016. Although men are more likely to die
from misusing pain relievers than women, the CDC (2013) reported that about 18 women
die every day from prescription pain reliever overdose with 6,600 deaths in 2010. Apart
from death, consequences affect unborn children when pregnant women misuse pain
relievers. Neonatal abstinence syndrome (NAS) is on the rise due to the increasing use of
pain relievers by pregnant women (Krans & Patrick, 2016). NAS is a withdrawal
syndrome that affects infants exposed to pain relievers during pregnancy and symptoms
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such as seizures, respiratory complications, feeding difficulties, and low birth weights are
seen shortly after delivery (Krans & Patrick, 2016). According to Krans and Patrick
(2016), most NAS admissions of infants are likely to be Caucasians.

Population and Demographics
The United States is one of the more developed countries in the world with an
estimated population of over 320,000,000. China and India are the only countries with
higher populations. According to the World Health Organization ([WHO] 2019), the
population in 2016 was 322,180,000 with a life expectancy at birth of 76 years for men
and 81 years for women. In 2019 the population was estimated to be 328,239,523 with
22.4% being those under the age of 18. Those above 65 years of age were 16% of the
total population and the total female population was 50.8% (“U.S. Census Bureau
QuickFacts: United States,” [USCB QuickFacts], 2019).
Although the United States is cosmopolitan, the Caucasian population forms the
highest percentage compared to other races. According to USCB QuickFacts, (n.d.-a),
76.5% of the population in 2019 was made up of Caucasians while African Americans
were 13.4%. Out of the Caucasian population, the Hispanic or Latino were 18.3% and
White alone, not Hispanic or Latino was 60.4%. Based on education, according to USCB
QuickFacts, 87.7% of the population aged above 25 years and above had a high school
diploma or higher in 2019 in the United States, which was slightly higher than what was
reported in 2018. USCB QuickFacts reported that 87.3% of the population aged 25 years
and above had a high school diploma or higher in 2018. The Demographic Statistical
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Atlas of the United States - Statistical Atlas (2018) also reported that 48.5% of the
population aged 25 years and older had a high school diploma.
Statement of the Problem
Pregnant women are considered as a vulnerable population in terms of taking a
relatively higher share of the disease burden, especially during disasters and emergencies
(WHO, 2012). Children, the elderly, and immunosuppressed people are also considered
vulnerable (WHO, 2012). Joszt (2018) stated that health and healthcare issues for
vulnerable populations may be worsened by social factors that lead to worse access to
care, increasing their morbidity and mortality compared to the general population. They
also experience greater risk factors due to their vulnerability (Joszt, 2018).
Pain can be experienced by anyone, and pregnant women are no exception.
Pregnancy, which is considered a normal part of life, comes with different experiences by
the expecting mothers, and these can include pain requiring interventions. According to
Coluzzi et al. (2014), pre-existing conditions such as low back pain, rheumatoid arthritis,
and fibromyalgia can cause chronic pain. Postural and hormonal changes during
pregnancy can also lead to pain and discomfort (Coluzzi et al., 2014; Jankiewicz et al.,
2015). Coluzzi et al. (2014) stated that pain management in pregnancy is a challenge.
The management of pain experienced by pregnant women poses a challenge to
clinicians especially considering the effects of the regimen on unborn babies. With many
clinicians fearing to prescribe pain relievers to pregnant women, some pregnant women,
therefore, may decide to self-medicate to relieve pain leading to misuse of the pain
relievers. U. S. Department of Health and Human Services ([HHS], 2019) and Volk
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(2019) stated that the misuse of prescription drugs is the fastest-growing problem in the
United States.
This introduces the issue of health literacy. As stated earlier, a high percentage of
American residents aged above 25 years had a high school diploma or higher in 2019
(USCB QuickFacts, 2019). Erik Schmidt (2018) reported in the US Census Bureau that
this is high, since in 1940 only 24% of the population aged 25 years and above completed
4 years of high school or more. Education and other factors affect health literacy which
helps individuals obtain, process, and understand basic health information and make
appropriate health decisions (Brooks, 2019; Healthy People.gov, 2020). With a high
population having attained a high school diploma or more, the link between education
and misusing prescription pain relievers is important to study.
There is a need to develop guidelines on pain management by obstetricians as
stated by Ray-Griffith et al.(2018). According to Ray-Griffith et al., many chronic pain
programs exclude pregnant women as they have pregnancy as an exclusion criterion, and
this means all pain issues are left solely to the obstetricians. Findings from this study will
provide information especially on education and race as variables that can guide the
development of guidelines targeted at the specific populations.
Specific Purpose of the Study
One important public health goal in the United States is to improve the health,
safety, and well-being of mothers, infants, and children. In achieving this, the health of
their families is also improved, as stated by HHS (2014). Factors such as age, poverty,
and perinatal health care affect pregnancy and childbirth. Determinants that influence
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maternal health also influence the health of the children, and HHS (2014) stated that
racial and ethnic disparities exist in the mortality of infants. The development of infants
and children is influenced by factors such as health, nutrition, and behaviors during
pregnancy and early childhood (HHS, 2014). Objective 11 of the maternal-infant and
child health (MICH 11) aims to increase abstinence from alcohol, cigarettes, and illicit
drugs with 11.4 focusing on illicit drugs (HHS, 2014). Misusing pain relievers during this
period is one such factor.
Goal 3 of the sustainable development goals (SDGs) which aims to ensure healthy
lives for all has Target 3.5 addressing the prevention and treatment of substance abuse.
Strengthening the prevention of substance abuse and treating those who abuse substances
including narcotics and alcohol can be addressed by discussing pain reliever misuse.
Findings from this study may include statistically significant associations between factors
such as education and race and misusing pain relievers can aid in substance abuse
prevention strategies. Stigma is the main concern with people who misuse drugs, and
Health Poverty Action ([HPA] 2015) stated that people who use drugs are denied health
care due to their drug use. HPA (2015) further elaborated this, stating that pregnant
women face strong social stigma and get denied perinatal care including that of opioid
substitution therapy and this affects their health and that of their unborn babies. The
expenditure by states on narcotic services is also affected by this stigma (HPA, 2015).
The goal is to strengthen the prevention and treatment of substance abuse especially with
people with substance use disorders who receive treatment services. This study
investigated the misuse of pain relievers by pregnant women in the United States.
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Research Questions and Hypotheses
The following research questions guided this study:
RQ1: Is there an association between race and pain reliever misuse among
pregnant women in the USA?
H01: There is not an association between race and pain reliever misuse among
pregnant women in the USA.
Ha1: There is an association between race and pain reliever misuse among
pregnant women in the USA.
RQ2: Is there an association between education level and pain reliever misuse
among pregnant women in the USA?
H02: There is not an association between education level and pain reliever misuse
among pregnant women in the USA.
Ha2: There is an association between education level and pain reliever misuse
among pregnant women in the USA.
Operational Definition of Terms
Pain reliever – A drug that is used to relieve, reduce or eliminate pain is referred
to as a pain reliever, and this could be opioid, narcotic, or non-opioid (Stempniak, 2016).
Pain reliever misuse – Pain reliver misuse refers to consumption of pain relievers
in a way other than as prescribed by the doctor or using the pain relievers from nonmedical sources. The use of these pain relievers for non-medical reasons or recreational
reasons can also describe pain reliever misuse (LeClair et al., 2015; McCabe et al., 2013).
Three specific ways of misusing a pain reliever are described in NSDUH: using it without
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a prescription of your own; using it in greater amounts, more often, or longer than one
was told to take it; and using it in any other way a doctor did not direct you to use it.
Pregnant women – The term pregnant women comes from the word pregnancy,
which according to NIH (2017) describes the period when the fetus develops in a
woman’s uterus and lasts for about 40 weeks when measured from the last menstrual
period to delivery and is divided into three trimesters. Women in this condition are
considered pregnant women. NSDUH relied on self-report on pregnancy questions. This
study focused on all the women who were pregnant during the NSDUH of 2016.
Nature of the Study
Understanding the association between misusing pain relievers and social
determinants of health such as education level, social-economic status, and race in
pregnant women was done using secondary analysis of data from a countrywide survey.
This is a cross-sectional study where two research questions will guide the research
identifying variables that will answer them hence have an analysis plan; check the
strengths and weaknesses of the dataset including describing the study population,
sampling scheme and strategy, time when data was collected, assessment tools, response
levels, and quality control measures; generate operational definitions of the variables
including the confounders; and run the analysis starting with frequency tables and crosstabulation (Cheng & Phillips, 2014).
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Literature Review
Literature Search Strategy
Extensive scholarly search for journals, articles, and books done through the
Walden Library was the main strategy used to find the relevant information for this study.
I primarily used the Health Sciences databases including CINAHL & MEDLINE
Combined Search, CINAHL Plus with Full Text, MEDLINE with Full Text, ProQuest
Health & Medical Collection, Elsevier Publishing Company, and PubMed. Media from
Walden Library such as those in statistics were also used. Other databases searched
included Google Scholar, CDC, WHO, and dissertations from former Walden Students
from the same program of DrPH.
Key Search Terms
Key search terms used during literature review include prescription pain
reliever/painkiller misuse and pregnancy, pain, opioid misuse, substance abuse, drug
abuse, Health Belief Model, medication-assisted treatment/MAT, cross-sectional study,
secondary analysis, dichotomization and variables, multiple logistic binary regression,
and regression coefficient. Other terms used are pain management or pain relief or pain
control or pain reduction. Determinants of health, race, and pregnancy, education and
pregnancy, and SDGs are other key terms used.
Theoretical Framework
The Health Belief Model (HBM), which aims to predict health-related behavior in
terms of certain health beliefs, guided this study. The HBM as described by Boston
University School of Public Health ([BUSPH] 2019) was developed in the 1950s by
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social scientists Irwin M. Rosenstock, Godfrey M. Hochbaum, S. Stephen Kegeles, and
Hoard Loventhal at the U.S. Public Health Service in order to understand why people
failed to adopt disease prevention strategies and screening tests for early detection of
disease. The HBM is used to explain change and behavior maintenance as well as to
guide health behavior interventions as explained by Glanz et al. (2008). This model
focuses on an individual’s perceptions of the threats posed by a health problem, the
benefits of avoiding those threats, and factors affecting or influencing the decisions to
act. Key concepts of HBM include perceived susceptibility or an individual’s likelihood
of getting the health problem, perceived severity or the seriousness of contracting the
health problem, perceived benefits or the potential benefits gained from changing
behavior, perceived barriers or potential negative aspects of the particular health action,
cues to action or what triggers them to act and self-efficacy or confidence in oneself to
perform the required action (Glanz et al., 2008; National Cancer Institute et al., 2005).
Figure 1
Diagrammatic Presentation of HBM
Modifying factors

Individual beliefs
Perceived susceptibility and
severity

Age
Gender
Ethnicity/race
Education

Perceived benefits

Socioeconomics
Knowledge
Education

Perceived self-efficacy

Perceived barriers

Actions
Perceived threats

Individual
behaviors

Cues to action
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Constructs of HBM and Misuse of Painkillers
Perceived susceptibility is further described as an individual’s perception of the
risk of acquiring a disease or condition. It is the belief about the likelihood of getting the
condition or disease (BUSPH, 2019; Glanz et al., 2008). Glanz et al. (2008) explained
this, stating that “...a woman must believe there is a possibility of getting breast cancer
before she will be interested in getting a mammogram.” (p. 47). As noted earlier, various
factors affect our health, with the environment and individual factors being significant
(Danawi, Bryant, & Hasbini, 2016). The key concepts of the HBM focus on the
individual’s perception and how they behave. Misusing pain relievers can be triggered by
how these individuals perceive the pain.
Perceived susceptibility is also explained by Parker and Anthony (2019) in their
study on underage use of alcohol and this being a predictor of misusing prescription pain
relievers. According to Parker and Anthony, underage drinking of alcohol should be a
factor considered by clinicians when prescribing pain relievers to people who start to
misuse prescription pain relievers. Mental disorders are also predictors of misusing
prescription pain relievers including opioids. Sanmartin et al. (2019) stated that major
depressive episode (MDE) is a common medical condition among women of
reproductive age, affecting about 10.4% compared to 5.5% of men. According to
Sanmartin et al., the risk of misusing opioids or having opioid use disorder among
women with MDE was almost double those without MDE. This further explains
perceived susceptibility.
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Perceived severity as explained by BUSPH (2019) is the individual’s feelings on
the seriousness of contracting the disease or condition. It also includes the feelings on the
seriousness of leaving it untreated after evaluating the clinical and medical consequences
such as pain and disability. Social consequences including the effects on their work and
relationships in the family and the community are also included (BUSPH, 2019; Glanz et
al., 2008). A combination of the individual’s beliefs on the likelihood of acquiring the
disease or condition and its seriousness as well as consequences if left untreated is the
perceived threat (Glanz et al., 2008).
The outcomes or benefits of performing certain actions to reduce the threats posed
by the disease or condition are the perceived benefits. According to Glanz et al. (2008), a
personal belief in the benefits of an action will influence their decision to take action to
reduce the threats. Glanz et al. further stated that an individual may not accept a
recommended action unless they perceive the action to be beneficial in reducing the
threat.
Impediments, obstacles, and anything that limits one to take the required actions
form the perceived barriers. Despite over 100 million Americans suffering from chronic
pain leading to disabilities, Ray-Griffith et al. (2018) stated that women are more
impacted than their male counterparts, and the pain thresholds of healthy women
increases throughout their pregnancies peaking just before delivery. Ray-Griffith et al.
further added that with back pain being a common ailment during pregnancy, there is
limited information or guidelines on how to manage this. The health care providers caring
for obstetrical patients, therefore, have limited time or inadequate training to provide the
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appropriate pain management to their clients (Ray-Griffith et al., 2018). This can be
viewed as one factor that brings out the construct of perceived barriers. Willis (2018)
stated that the construct of perceived barriers is the most significant of the HBM when
predicting behavior.
Education attainment also portrays perceived barriers since education is a strong
predictor of adult health as stated by Liu and Hummer (2008). According to Liu and
Hummer, educational disparities exist in terms of age, period, race/ethnicity, and gender,
and a higher level of education is associated with better health. These disparities have
been in existence since the early years and changed in the 1970s as stated by Madigan
(2009). According to Madigan, the passage of Title IX of the Education Amendment Act
of 1972 protected students from being discriminated against based on their genders.
Teenagers on the other hand have a weak understanding of the use of pain relievers as
stated by Silva et al. (2011), who described the understanding as weak. Pregnant women
include teenagers, and this is a significant barrier to their correct use of pain relievers.
The stimuli needed to trigger an individual to act form the cues to action (Boston
University School of Public Health, 2019). According to BUSPH (2019) and Glanz et al.
(2008), individuals may do a cost-benefit analysis of actions to be taken comparing the
expected benefits of taking the action and the barriers. Hence, a combination of the
perceived susceptibility and perceived benefits minus the perceived barriers leads to the
path of action.
Self-efficacy or the level of confidence an individual has in their ability in
performing a recommended action is important in behavior change (Glanz et al., 2008).
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An individual will perform the recommended action based on the level of confidence
they have in themselves, and this begins from the initiation of the recommended action to
its maintenance (Glanz et al., 2008). Educational attainment is a variable that influences
an individual’s perceptions indirectly, hence influencing their level of confidence in
performing actions. According to Glanz et al. (2008), education influences perceived
susceptibility, perceived severity, perceived benefits, and perceived barriers.
Misuse of Painkillers
Misuse of prescription pain relievers is increasing, posing both social and public
health concerns particularly in developed countries such as the United States. According
to LeClair et al. (2015), this can occur with or without a prescription. LeClair et al.
further stated that this habit is initiated during young adulthood with around 10.1% of
those aged between 18- and 25-years reporting having misused pain relievers in the last
year. Most people are unaware they have this problem and hence may not seek treatment.
An estimated 22 million Americans in 2005 struggled with drug or alcohol problems, and
the consequences of this have affected the quality of life for millions of individuals,
families, and communities across the world (Sung et al., 2005). McLellan, 2017 reported
that serious substance misuse including alcohol and prescription pain relievers, have
significant financial consequences citing costs of over $420 billion annually and over
$120 billion in healthcare.
Experimentation, normalization, and its use in combination with other substances
such as alcohol are some of the motivators for this behavior. According to LeClair et al.
(2015), young people may want to try new things. The acceptance by society that this is
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normal in managing school, leisure, and boredom also is a motivator for the behavior.
Other substances such as alcohol may require one to take pain relievers to moderate their
effects (LeClair et al., 2015; McCabe et al., 2013). McCabe et al. (2013) added that some
misuse pain relievers to get high, relieve tension, relax, or help sleep, and because these
are safer than street drugs.
Chronic pain impacts millions of people and is a major cause of lasting disability
in America (Ray-Griffith et al., 2018a). Women have a higher burden compared to men,
and Ray-Griffith et al. ( 2018) further added that the pain threshold in pregnant women
peaks just before delivery. As noted earlier, pain is common during pregnancy. Sinclair et
al. (2014) reported that 60% of pregnant women typically experience low back pain with
another 20% experiencing pelvic pain. Coluzzi et al. (2014) and Ray-Griffith et al. (2018)
noted that the management of chronic pain in pregnancy is a challenge for healthcare
providers and hence some pregnant women may misuse the prescribed pain relievers.
Coluzzi et al. (2014) argued that there is a risk of undertreatment of pain in
pregnant women due to fear of using certain drugs during pregnancy. According to
Elander et al. (2014), people with chronic pain can easily misuse pain relievers. Elander
et al. (2014) explained that the incorrect use of pain relievers is on the increase especially
because these pain relievers are also available over the counter (OTC). This is in
alignment with Maxwell (2011), who attributed the increasing trend of prescription
opioid misuse to factors such as inappropriate prescriptions and the wide availability both
legally and illegally.

16
The effects of the misuse of these substances can be grouped into those affecting
the mother and those affecting the child. According to Day and Sanju (2005), mothers
may have self-neglect in various aspects and may even engage in prostitution and
burglary to get their supplies due to dependence. The effects on the child trickle down
from maternal infections, poor nutrition, and neglect leading to low birth weight and high
incidence of preterm birth (Day & Sanju, 2005). Day and Sanju explained that exposure
during the first trimester affects the development of the fetus while exposure in the
second and third trimesters affects their growth and functioning.
Misuse of drugs begins during the early parts of life, and Chakravarthy et al.
(2013) stated that adolescent abuse is correlated to using drugs during adulthood and this
being problematic. Volk (2019) noted that the fastest-growing drug problem in the United
States is the use of prescription drugs affecting the lives of many. Stimulants that have
effects common with cocaine, pain relievers that have effects common with heroin, and
depressants are the ones mostly misused (Volk, 2019). Volk also stated that prescription
drug misuse affects judgment leading to an increase in risky behaviors. These may, in
turn, lead to pregnancy and the acquisition of sexually transmitted infections.
Anxiety and depression are some factors that lead to the misuse of prescription
pain relievers. Kozhimannil et al. (2017) in their retrospective study sampled pregnant
women aged 12 to 44 from the NSDUH 2005-2014 and reported a rate of 5.1% of nonmedical use of pain relievers and anxiety and depression were strong risk factors. Sung et
al. (2005) report that the African-American individuals, women, those of low
socioeconomic status, and those who view the use of pain relievers as favorable are at a
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higher risk of misusing prescription pain relievers among the youth. Using univariate and
multivariate models, variables such as age, gender, education, family income, and race,
among others, were analyzed and from their findings, Sung et al. recommend targeting
prevention measures to the at-risk groups.
A study by Okewole and Fadebi (2017) concluded that drug abuse affects the
performance of students in their academics. The analysis revealed that peer pressure was
a significant reason for getting involved in drug misuse. Okewole and Fadebi listed
getting over problems, deriving pleasure, and curiosity as some reasons for indulging in
drug misuse, which is in alignment with LeClair et al. (2015) and McCabe et al. (2013).
Counseling combined with other approaches was the most favorable strategy to be used
to reduce this menace (Okewole & Fadebi, 2017). According to Kozhimannil et al.
(2017) and Krans and Patrick (2016), medications such as methadone when used on
pregnant women are most effective when used in combination with counseling.
Policies and Programs
With the increasing use of pain relievers during pregnancy and the consequential
increase in NAS for the exposed infants, initiatives to improve access to treatment of
substance abuse by pregnant women are now in place (Krans & Patrick, 2016). Krans and
Patrick (2016) further added that criminalizing pregnant women with addiction is being
embraced by most states with substance abuse during pregnancy now classified as
criminal child abuse in 18 states and this could lead to the termination of parental rights.
This, however, may prevent mothers from seeking prenatal care, hence clinicians should
routinely screen all pregnant women for drugs and alcohol following the Health
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Insurance Portability and Accountability Act of 1996 (HIPPA) regulations (Krans &
Patrick, 2016).
Medication-assisted treatment (MAT) using methadone or buprenorphine is
recommended among pregnant women, and the benefits include reduced risk-taking
behavior decreasing the transmission of infectious diseases such as HIV and minimized
opioid withdrawal. MAT is most effective when used together with counseling or
behavioral therapy, hence health personnel should work together (Kozhimannil et al.,
2017; Krans & Patrick, 2016). For NAS, adherence to a single treatment regimen through
the standardization of care as given by the American Academy of Pediatrics resulted in
improved outcomes (Krans & Patrick, 2016).
To control the prescription of pain relievers, legislative initiatives addressing four
main pillars, namely, educating everyone including the public, tracking, and monitoring
of prescribers, proper disposal of medication, and the enforcement targeting pill mills and
doctor shopping, lead to better protection of mothers and infants (Krans & Patrick, 2016).
Social Change
The prevalence of misuse of prescription pain relievers including opioids
continues to rise and this poses a burden to the healthcare system. As earlier documented,
MAT is most effective when combined with behavioral therapy through counseling and a
standardized regimen works best for NAS (Krans & Patrick, 2016). Sehgal et al. (2012)
stated that there is no single instrument that can be used to screen patients who can
benefit from opioid therapy (MAT), and hence multiple tools and tests have to be used
together. These include risk assessments as well as urine tests. Sehgal et al. suggested
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that if there was one instrument for this task, iatrogenic addiction would be eliminated
and this would lead to better outcomes. Spada et al. (2019) also recommended studies
focusing on opioid agonist treatment in pregnant women to be carried out as this had
better outcomes compared to outpatient substance use treatment alone. The findings from
this study showed associations between race and the misuse of pain relievers among
pregnant women and thereby will guide the targeting of treatment regimens.
Victimization of those who seek help leads to shying away from health-seeking.
As such, Krans and Patrick (2016) reported that following HIPAA regulations is
essential. According to Sehgal et al. (2012), medical providers should be well-equipped
with legal and regulatory issues surrounding the use of prescription pain relievers and
pain relievers to manage chronic pain effectively while minimizing addiction at the same
time.
Understanding the association between misusing pain relievers and social
determinants of health will guide in the interventions geared towards managing chronic
pain among women of reproductive age hence addressing the public health concern.
Krans and Patrick (2016) as cited by Kozhimannil et al. (2017) stated that for better
prevention, screening, and treatment of nonmedical use of pain relievers, it is important
to understand the factors that lead to this behavior. Romero et al. (2016) also reported
that effective community interventions geared towards preventing teen pregnancies
should consider the social needs of the groups at risk and data can help in identifying
those with the greatest need.
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The highest rate of teenage pregnancies among developed countries is in the
United States, and young adults and teenagers make approximately 22% of the
population. With this in mind, Jankiewicz et al. (2015) reported that teenagers are not
well-represented in most studies and that pregnancy limits pain management options in
women due to the potential adverse effects on both the mother and the unborn baby. This
study focused on all pregnant women including teenagers. A focus on perinatal pain and
its management using evidence from studies was also recommended by Jankiewicz et al.
(2015) and Ray-Griffith et al. (2018), as the perinatal and postnatal periods are
understudied. Understanding factors that are associated with misusing pain relievers early
in life will, therefore, give the necessary scientific evidence in the management of pain in
pregnancy, and hence findings from this study with pregnant women as the main subjects
will play a significant role in this. As reported by Romero et al. (2016), addressing the
social conditions using effective community-based interventions will reduce disparities
especially when those with the greatest need are focused on.
Even as the United States has a high rate of teen pregnancies compared to other
developed countries, there exists a disparity in the distribution. According to Romero et
al. (2016), racial, ethnic, and geographical disparities should be considered in the
prevention strategies. To achieve health equity, unemployment, access to education, and
higher family income can be addressed by community-level interventions (Romero et al.,
2016). The Robert Wood Johnson Foundation (RWJF), whose vision is to give everyone
an equal opportunity to the healthiest life regardless of their different races, income, and
living environments, requires collaboration by various sectors to deal with these

21
problems. Guided by 10 principles and the involvement of every individual in the society,
a culture of health with healthy communities and lifestyles is built (Robert Wood Johnson
Foundation, 2020). The collaboration will, therefore, achieve good health for the
population (Plough, 2015). Creating a culture around health through health education and
behavior change is a broad approach to achieving good health in the population, as stated
by Mockenhaupt and Woodrum (2015). Addressing the issue of pain reliever misuse
among pregnant women is a step towards achieving a culture of health in our society.
CDC (2018) reported that the rate of teen pregnancies among Hispanic teens and
non-Hispanic African-American teens was more than double that of the non-Hispanic
Caucasian teens in 2017. American Indian/Alaska Native teens had the highest rate
among all the races/ethnicities (CDC, 2018). This is in alignment with King Bowes et al.
(2018), who stated that American Indian and Alaska Native (AI/AN) adolescents are at a
higher risk for adverse sexual and reproductive health outcomes due to the lack of
culturally appropriate sexual education reporting the early onset of sexual activity as well
as higher numbers of sexual partners compared to the general population. According to
Romero et al. (2016), Sedgh et al. (2015), and Sung et al. (2005), there is a higher rate of
teen pregnancy among the Black race. Studying race as a predictor to whether pregnant
women misuse prescription pain relievers will yield results that can be used to gear
prevention strategies to this behavior and in the long run, address issues affecting most
pregnant women including teenagers.
About 50% of pregnancies in the United States have been reported to be
unplanned (American Society of Addiction Medicine, [ASAM] 2017). This percentage
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could be as high as 80% among women with substance use disorders ASAM, 2017).
Policies on substance use, misuse, and use disorders during any stage of pregnancy and
after delivery are important and hence screening women for their intention to get
pregnant, prioritizing their treatment, educating them on issues regarding substance use
and its effects on pregnancy, and regulatory and legal issues concerning these pregnant
women are addressed in substance use programs (ASAM, 2017). This knowledge
empowers them despite their substance use habits and depicts the construct of selfefficacy and leads to positive social change.
Summary
In this section, a foundation of the study was presented including discussions on
the gaps in knowledge and the problem statement. The purpose of this study was also
discussed. An introduction of the research questions, the related null and alternative
hypotheses, and the theoretical framework guiding the study were also discussed. The
nature of the study and the literature search strategy together with the literature review
described ways that other research has been done, and the review guided the study in
terms of the implications on positive social change it will have. Programs and policies in
drug misuse were also discussed. The next section describes the methodology and study
design used.
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Section 2: Research Design and Data Collection
Introduction
Understanding the associations between misusing pain relievers and social
determinants of health such as education level and race in pregnant women was done
using secondary analysis of data from a countrywide survey. The National Survey on
Drug Use and Health data set of 2016, labeled NSDUH-2016-DS0001. was used. A
sample from the data was analyzed and findings reported and generalized to the
population. This is a cross-sectional study where two research questions guided the
research. El-Masri (2017) stated that researchers have the aim of concluding populations
that have characteristics that interest them and since they may not be able to study the
entire population due to time, cost, and logistical constraints, research participants with
the characteristics are selected randomly or non-randomly from that target population.
Findings from the selected sample, also known as the study sample, will then be
generalizable to the entire population especially when it is representative of the
population (El-Masri, 2017).
Quantitative, qualitative, and mixed methods are the approaches of conducting
research, and Regoniel (2015) stated that those research methods that use numbers to
generalize phenomena are quantitative. Measurable information and data such as age,
educational status, and socio-economic status among others are collected using
standardized and pre-tested instruments. A normal population distribution curve can be
drawn, hence proper sampling from the target population should be done for proper
generalization of the findings. This study is quantitative as it has two research questions
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and measurable variables such as education, the number of women of a certain race, and
the number of women who are pregnant and their ages.
Target Population
Pregnant women of all ages from the NSDUH of 2016 formed the study
population. NSDUH measures the illegal use of prescription and non-prescription drugs
as well as mental disorders. The illegal use of common substances such as alcohol and
tobacco are also measured (HHS, n.d.). According to HHS (n.d.), respondents to the
survey’s face-to-face interviews are aged above 12 years, US civilians, and not
institutionalized. This study focused on the misuse of pain relievers including Vicodin,
OxyContin, Percocet, and others by pregnant women who were surveyed. Some other
pain reliever (coded 37) was also included, and OTC pain relievers such as Tylenol,
aspirin, Advil, and Aleve were excluded.
Pregnant women have been excluded in most researches, and van der Graaf et
al.(2019) stated that this reluctance is mainly due to the fear of harming the fetus. The
reasons are valid, but van der Graaf et al. explained that there is a need for evidencebased information from the pregnant women themselves. Pregnant women get sick or
experience pain, and women who are sick or in pain get pregnant, so including them in
research is important to achieve positive outcomes (van der Graaf et al., 2019). Targeting
this group using data from a nation-wide survey gave findings that can be generalizable
to the entire population of the United States.
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Sampling Procedures and Sample Size Determination
The NSDUH uses multistage area probability sampling methods to select their
respondents for participation in the survey. According to SAMHSA(2017), stratification
and first-, second-, and third-stage sample selections were done. A more detailed
description of the design and sampling used in the NSDUH is available in the report
(SAMHSA, 2017). Salas-Wright et al. (2015) in their study restricted their analysis to
female respondents within the target age group. This study focused on all pregnant
women and analysis was restricted to them.
Inclusion and Exclusion Criteria
Ethical considerations must be followed when dealing with human subjects, and
the NSDUH used respondents aged above 12 years who were US civilians and were not
institutionalized. According to SAMHSA (2017), all civilian residents of the 50 states
and the District of Columbia who were not institutionalized and were aged above 12 were
included in the national survey. Lofquist et al. (2012) reported that during the 2010
census, 300.8 million people of the 308.7 million people were living in households in the
United States. This was approximately 97%of the total population then. Hence
respondents aged 12 and above who were non-institutionalized civilians would represent
approximately 97% of the entire population.
According to SAMHSA (2017), those with no fixed household address such as
the homeless and/or transient persons not in shelters, the active military personnel, and
those residing in institutions such as hospitals and jails were excluded in the survey.
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Power Analysis for Sample Size Determination
Identification of an appropriate sample size requires the level of statistical
significance, alpha; the power desired to test the null hypothesis when it is false, beta;
and the effect size which is the expected difference between the means (Creswell, 2014).
Sawilowsky (2009) explained that Cohen in 1988 defined the effect size d = 0.2, 0.5, and
0.8 as small, medium, and large. Larger and smaller values of d have been reported in
different research studies, hence Sawilowsky revised the values of d as d (0.01) = very
small, d (0.2) = small, d (0.5) = medium, d (0.8) = large, d (1.2) = very large, and d (2.0)
= huge.
Using G*Power 3.1.9.4 (Faul et al., 2009) to test whether the dichotomized
independent variables were significant predictors of misusing prescription pain relievers,
a minimum sample size of 333 was needed. Power analysis as explained by (Sawilowsky,
2009) and testing of the model whether the independent variables, race, and education,
predict the dependent variable, misuse of prescription pain relievers was done using a
level of significance, α, set at 0.05. To achieve a power of 0.8 or 80 % and a medium
effect size, a minimum sample of 333 was required to detect a significant model. There
was an 80% chance of correctly rejecting the null hypothesis that race and education level
were not associated with misuse of prescription pain relievers with 333 participants.
Jenkins and Quintana-Ascencio (2020) explained that low sample sizes lead to
challenges in reproducibility in research recommending a sample size N ≥ 8 for data with
very low variance and N ≥ 25 for data with high variance. A minimum sample size of 333
would detect a significant model and is greater than 8 and 25.
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Datasets and Variables
Based on my topic and research questions, the NSDUH-2016-DS0001 was used
for the secondary analysis. The use of pain-relievers when not directed by doctor labeled
PNRNMLIF was the dependent variable which was categorical in nature with 8 choices
(1 = Yes, 2 = No, 5 = Yes LOGICALLY ASSIGNED (from skip pattern), 85 = BAD
DATA logically assigned, 91 = NEVER USED/MISUSED PAIN RELIEVERS, 94 =
DON’T KNOW, 97 = REFUSED, 98 = BLANK (NO ANSWER). Pregnancy status
(PREGNANT labeled 1), race (NEWRACE2) which was categorical with 7 choices (1 =
NonHisp White, 2 = NonHisp Black/Afr Am, 3 = NonHisp Native Am/AK Native, 4 =
NnHisp Native HI/Other Pac Isl, 5 = NonHisp Asian, 6 = NonHisp more than one race
and 7 = Hispanic), and education status (EDUHIGHCAT) which was categorical with 5
choices (1 = Less high school, 2 = High school grad, 3 = Some coll/Assoc Dg, 4 =
College graduate and 5 = 12 to 17 year olds) were the independent variables.
Research Questions
The following research questions guided this study in finding out if there were
any associations between the variables:
RQ1: Is there an association between race and pain reliever misuse among
pregnant women in the USA?
H01: There is not an association between race and pain reliever misuse among
pregnant women in the USA.
Ha1: There is an association between race and pain reliever misuse among
pregnant women in the USA.
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RQ2: Is there an association between education level and pain reliever misuse
among pregnant women in the USA?
H02: There is not an association between education level and pain reliever misuse
among pregnant women in the USA.
Ha2: There is an association between education level and pain reliever misuse
among pregnant women in the USA.
Analytical Strategies
SPSS was used to import the data and run frequency tables and cross-tabulations
and is presented in the form of bar graphs and pie charts for descriptive analysis. The
dependent and independent variables were categorical. For pain-reliever misuse,
PRNMLIF focus was on choices 1 (YES) and 0 (NO), and the rest were treated as
missing data. As discussed earlier, American Indian and Alaska Native adolescents are at
a higher risk for adverse sexual and reproductive health outcomes due to lack of
culturally appropriate sexual education as stated by King Bowes et al. (2018), and
Romero et al. (2016), Sedgh et al. (2015), and Sung et al. (2005) stated that there is a
higher rate of teen pregnancy among the African-American population. Race
(NEWRACE2), which had seven choices, was, therefore, dichotomized into AfricanAmerican (1) and non-African-American (0). For EDUHIGHCAT, the five choices were
dichotomized into 0 = less high school and 1 = High school grad and above.
Since my research questions were on associations between the binary dependent
and independent variables, multiple logistic binary regression was used. Multiple logistic
binary regression applies when there is a single dichotomous outcome and more than one
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independent variable (McDonald, 2015). The aim is to find an equation that best predicts
the probability of the value of the dependent variable as a function of the independent
variables. It is a predictive analysis used to understand the functional relationship
between the independent variables and the dichotomous dependent variable (McDonald,
2015). This helped me identify the existence of any associations between the variables
and confounders could also be accounted for (Laureate Education, 2016a; Laureate
Education, 2016b). SPSS outputs were also used.
According to Statistics Solutions (n.d.) using multiple logistic binary regression
means that six assumptions must be met, and these are:
1. The dependent variable should be binary - use of pain-relievers when not
directed by doctor labeled PNRNMLIF focused on 1 = YES and 2 = NO choices
hence binary in nature.
2. Since it assumes that P(Y-1) is the probability of the event occurring, the
dependent variable must be coded accordingly i.e. for a binary regression, the
factor level 1 of the dependent variable should represent the desired outcome.
For this study, PNRNMLIF 1 = YES.
3. Model fitting with only meaningful variables being included – missing data was
excluded.
4. No multicollinearity – multiple linear regressions were run to determine this.
5. The linearity of independent variables and log-odds
6. Requires large sample – NSDUH is a national survey and this study focused on
all women who are pregnant.
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The goodness of fit was determined using Pearson’s chi-square statistic where
large chi-square values indicate a poor fit for the model. A statistically significant result
(p < 0.05) indicates that the data do not fit the model well. Hosmer Lemeshow test also
determine if the observed values match the expected values in population subgroups. If
the values are the same, you have a model that fits perfectly. These tests determine if
findings from the study are representative of the population from which the sample was
selected from.
The regression coefficient (B) is the coefficient for the constant given in log odds.
In logistic regression, the Exp(B) is the exponentiation of the B coefficient and is an odds
ratio and is easier to interpret. According to Mathew Jones in Laureate Education,
(2017d), an odds ratio of 1.00 means all things are equal and if B is negative then the
Exp(B) will be less than one hence decreasing the odds and vice versa. Variables with
significance levels p <.05 will be interpreted.
Most researchers present results based on a 95% confidence interval as stated by
Pourhoseingholi et al. (2013), and this study will also report results based on a 95%
confidence interval. For more confidence in the results, a higher percentage can be used.
Threats to Validity
The design and methods of research contribute to how sound the study is, and
these, in turn, lead to the generalizability of findings to the population from which the
study subjects were sampled. Internal validity is affected by factors within the study itself
and the results deviate from the truth hence no conclusions can be drawn (Patino &
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Ferreira, 2018). Without internal validity, external validity is irrelevant as stated by
Patino and Ferreira (2018).
Internal Validity
The NSDUH is conducted yearly since 1971 and administered by SAMHSA and
provides data on tobacco use, alcohol, illicit drugs (including non-medical use of
prescription drugs such as pain relievers), and mental health issues in all the 50 states in
the USA (National Institute on Drug Abuse [NIDA], 2018). According to NIDA (2018),
RTI International, a non-profit research organization based in North Carolina, has
conducted it since 1988.
Drawing conclusions and making correct inferences is important, hence internal
validity checked in this study include the history which ensures that all study participants
experience the same external events; maturation which entails selecting study participants
who may change or mature at about the same rate. For this particular study, the study
population is all pregnant women, and comparisons, was done according to age groups
(Creswell, 2014).
Another component is regression/subject variability, which ensures that study
participants with almost similar characteristics are selected (Creswell, 2014). Restricting
the analysis to all the pregnant women surveyed fulfills the component of subject
variability as described above and selection which involves the process of using random
selection to get a fair distribution of study participants (Creswell, 2014). Mortality and
instrumentation/task sensitivity are other components addressed by using a large sample
size to account for dropouts and maintaining the same instrumentation during the
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research (Creswell, 2014). NSDUH uses the same survey tool to collect data from all the
study participants in the 50 states (SAMHSA, 2017).
External Validity
The extent to which findings can be generalizable to other groups or contexts
depends on their external validity. Incorrect inferences from study samples made to other
people or settings and to different times lead to threats in external validity (Creswell,
2014). The study subjects are described using the inclusion and exclusion criteria and this
meets the external validity component of describing the population characteristics. In the
NSDUH according to (SAMHSA, 2017) all civilian residents of the 50 states and the
District of Columbia who were not institutionalized and were aged above 12 were
included in the national survey and this study focused on all pregnant women.
Generalizing findings to this population in the United States, therefore, is in alignment.
The effect of time is another external validity factor and NSDUH is conducted
yearly hence can find out if results can be replicated (Creswell, 2014). Data collection
methodology for NSDUH, according to SAMHSA (2017), was stratification and first-,
second-, and third-stage sample selections were done with a more detailed description of
the design and sampling utilized made available in their report.
External validity is increased by using broad inclusion criteria resulting in a study
population that closely resembles the real-world population (Patino & Ferreira, 2018).
Ethical Considerations
Ethical considerations aim to protect the respondents and participants so that they
are confident in giving their responses and in participating (Osho, 2017). Walden
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University Ethics Committee/Institutional Review Board (IRB) reviewed the proposal
and was approved on 9/14/2020 after meeting their ethical standards (Approval number
09-14-20-0575030).
For this study, a secondary analysis of the NSDUH-2016-DS0001 dataset was
done. Directed by SAMHSA which is a Department of Health and Human Services
agency, the NSDUH of 2016 applied ethical considerations especially in the recruitment
of the study participants where those with no fixed household addresses, the active
military personnel, and those residing in institutions such as jails were excluded
(SAMHSA, 2017).
Ethical considerations include principles of ethics such as respect for persons by
acknowledging their autonomy and protecting their diminished autonomy (Yip, Han, &
Sng, 2016). In this study, as seen in the NSDUH survey, voluntary involvement and
exclusion of those who were institutionalized, those who were homeless, as well as those
in active duty with the military was applied. Yip et al. (2016) also stated that beneficence
and justice are important principles meaning doing no harm and being fair. According to
SAMHSA (2017), NSDUH’s main aim is to measure the illegal use of prescription and
non-prescription drugs as well as mental disorders and with multi-stage sampling, all
regions are well-represented.
Summary
This section presents the research design and methodology used for the study.
This is done by describing the NSDUH of 2016 giving characteristics of the population
and how they were selected for the survey. The research population is also described and
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a brief discussion on the sampling procedure done in the NSDUH of 2016, variables of
interest, threats to validity, ethical considerations, and limitations of the study are also
presented. The next section will present the results and findings in alignment with the
research questions guiding it.
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Section 3: Presentation of the Results and Findings
Introduction
This study was conducted to investigate the misuse of pain relievers by pregnant
women in the USA. Using data from the NSDUH of 2016 and two research questions,
this cross-sectional study was designed to understand the relationship between misusing
pain relievers and variables such as education and race among pregnant women.
To ensure only the target population was studied, the data were filtered by
selecting only those respondents who responded Yes (1) to be pregnant. This is because
this study was focusing on pregnant women. To achieve the best and most meaningful
analysis, the data set and corresponding codebook of the NSDUH 2016 were adjusted to
adequately reflect the variables of interest. The dependent variable, for example, was
recoded to have two possible outcomes, Yes (1) and No (0), with Yes, logically assigned
and Never used/misused pain relievers being assigned as Yes and No respectively.
As earlier stated, the race of focus was the African-Americans, and the education
level was whether one had a high school diploma or higher. These variables were
dichotomized with 1 representing African-American while 0 represented all the other
races, and for education 1 represented high school diploma and higher while 0
represented below high school and those aged 12 to 17.
According to the inclusion criteria for this study focusing on pregnant women, the
final sample size was 732 pregnant women. With the adjustments, the following research
questions and their respective null and alternative hypothesis guided the study:
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RQ1: Is there an association between race and pain reliever misuse among
pregnant women in the USA?
H01: There is not an association between race and pain reliever misuse among
pregnant women in the USA.
Ha1: There is an association between race and pain reliever misuse among
pregnant women in the USA.
RQ2: Is there an association between education level and pain reliever misuse
among pregnant women in the USA?
H02: There is not an association between education level and pain reliever misuse
among pregnant women in the USA.
Ha2: There is an association between education level and pain reliever misuse
among pregnant women in the USA.
Descriptive Demographics of the Sample
For the 732 pregnant women surveyed in 2016, 84 (11.5%) misused pain relievers
and 648 (88.5%) did not misuse pain relievers as depicted in Table 1 below.
Table 1
Distribution of Pregnant Women According to Misuse Vs Non-Misuse of Prescription
Pain Relievers (N=732)
Prescription pain reliever
misuse
Yes
No

N

%

84
648

11.5
88.5
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Table 2 shows the distribution of pregnant women according to age. Most of the
women were aged between 18 and 44 years (96.6%). Figure 1 is a pie chart showing the
distribution of pregnant women according to age.
Table 2
Distribution of Pregnant Women According to Age (N=732)
Pregnancy age
1 – 15-17 years old
2 – 18-25 years old
3 – 26-44 years old
4 – otherwise

N
21
335
372
4

Figure 2
Distribution of Pregnant Women According to Age

%
2.9
45.8
50.8
0.5
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Tables 3 and 4 show the distribution of the pregnant women according to race and
the crosstabulation respectively. Most of the pregnant women were non-AfricanAmerican (85.1%).
Table 3
Distribution of Pregnant Women According to Race (N=732)
Race
African-American
Non-African-American

N
109
623

%
14.9
85.1

Table 4
Race * Pain Reliever Misuse Crosstabulation
Pain reliever misuse
0
1
Race
0
540
83
1
108
1
Total
648
84

Total
623
109
732

Tables 5 and 6 show the distribution of the pregnant women according to
education level and the crosstabulation respectively. Most of the pregnant women had a
high school diploma and higher (84.2%).
Table 5
Distribution of Pregnant Women According to Education Level (N=732)
Education

N

%

High school and above

616

84.2

Below high school

116

16.8
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Table 6
Education * Pain Reliever Misuse Crosstabulation
Pain reliever misuse
0
1
Education
0
104
12
1
544
72
Total
648
84

Total
116
616
732

Study Results
Table 7 below shows the prescription pain relievers misused in the past 12 months with
hydrocodone being misused by eight pregnant women.
Table 7
Last Pain Reliever Used by Pregnant Women not Directed by the Doctor in the Past
12 Months
Last pain reliever used
1 - Vicodin
2 - Lortab
5 - Hydrocodone
6 - OxyContin
7 - Percocet
10 - Oxycodone
12 - Ultram ER
14 - Tramadol
16 - Tylenol with codeine 3
or 4
17 - Codeine pills
26 - Suboxone
27 - Buprenorphine
37 - Some other pain
reliever

N
4
1
8
3
2
1
1
1
4

%
12.1%
3.0%
24.2%
9.1%
6.1%
3.0%
3.0%
3.0%
12.1%

1
4
2
1

3.0%
12.1%
6.1%
3.0%

Table 8 presents the chi-square tests with the statistics being the same (21.301)
since no stepwise logistic regression was used and no blocking was done. The chi square
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test is done to determine if there is any relationship between the variables. The p value,
0.000 is the probability of obtaining the chi-square statistic, given that the null hypothesis
is true. This is the probability of obtaining 21.301 if there is no effect that race and
education level, taken together, have on the misuse of prescription pain relievers by the
pregnant women. The p-value, 0.000 is less than 0.05 which is our critical value hence
the model is statistically significant and not just by chance.
Table 8
Omnibus Tests of Model Coefficients
Step 1

Step
Block
Model

Chi-square
21.201
21.301
21.301

df
2
2
2

Sig.
.000
.000
.000

Table 9 presents Cox & Snell R-square and Nagelkerke R-square values (between
0 and 1) to show the goodness of fit of the model of this study data. Approximately 3%
and 6% of the variability in the misuse of prescription pain relievers is explained by both
race and education level as demonstrated by the Cox & Snell R2 = .029 and the
Nagelkerke R2=.056. Cox & Snell R-square summarizes the proportion of variance in the
dependent variable associated with the predictor (independent) variables; however, its
value range is between 0 and < 1. Nagelkerke R-square corrects this, adjusting the scale
to cover 0 to 1.
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Table 9
Model Summary
Step

-2 Log likelihood

Cox & Snell R
Nagelkerke R
Square
Square
1
500.383a
.029
.056
a. Estimation terminated at iteration number 7 because parameter changed by less than
.001.

In Table 10, the Hosmer-Lemeshow test is non-significant since the value .940 is
greater than .05 and this indicates a good model fit, while Table 11 is the contingency
table for the Hosmer and Lemeshow Test with the observed and expected values being
almost similar (71 observed vs 71.223 expected and 461 observed vs 460.777 expected as
two examples) which also indicates a good model fit hence the sample is representative
of the population (external validity).
Table 10
Hosmer-Lemeshow Test
Step
1

Chi-square
.006

df
1

Sig.
.940

Table 11
Contingency Table for Hosmer-Lemeshow Test
Misused

Step 1

Did not misuse

Observed

Expected

Observed

Expected

1

71

71.223

461

460.777

532

2

12

11.777

79

79.223

91

3

1

1.000

108

108.000

109
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On the classification, the specificity of the model was at 0% while the sensitivity
of the model was at 100% with an overall classification percentage of 88.5. Table 12
depicts this below.
Table 12
Specificity and Sensitivity of the Model
Predicted
Pain reliever misuse
Yes
No

Observed
Step 1

Pain reliever
misuse
Overall
percentage
a. The cut value is .500

Yes
No

0
0

84
648

Percentage
correct
.0
100.0
88.5

For the binary logistic regression, Table 13 below shows that education level high
school and above is not a significant predictor of misusing prescription pain relievers
(b=-.039, se=.334, and sig=.907) since the significance level is .907 which is greater than
.05. African-American race on the other hand is a negative and significant (b=-2.806,
se=1.012 and sig=.006) predictor of the probability of misusing prescription pain
relievers among pregnant women in the USA.
Research question 1 stated as follows:
RQ1: Is there an association between race and pain reliever misuse among
pregnant women in the USA?
H01: There is not an association between race and pain reliever misuse among
pregnant women in the USA.
The null hypothesis was tested, using the Wald test for the strength of the
significance between the predictive model and race. The African-American race is a
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negative and significant (b=-2.806, se=1.012, Wald=7.691, and sig=.006) predictor of the
probability of misusing prescription pain relievers. The OR indicates that for every
pregnant woman of the non-African-American race, the odds of misusing prescription
pain relievers decrease by 6% in the pregnant women of the African-American race. This
means that the African-American race had a lower odds/probability of misusing
prescription pain relievers. P-value 0.006 is less than 0.05 hence at 95% confidence level
we fail to reject the null hypothesis and conclude that African-American race is a
predictor of misusing prescription pain relievers among pregnant women in the USA.
Research question 2 stated as follows:
RQ2: Is there an association between education level and pain reliever misuse
among pregnant women in the USA?
H02: There is not an association between education level and pain reliever misuse
among pregnant women in the USA.
The null hypothesis was tested, using the Wald test for the strength of the
significance between the predictive model and education level. Education level is a nonsignificant predictor of the probability of misusing prescription pain relievers (b=-.039,
se=.334, Wald=0.014, and sig=.907). P-value 0.907 is greater than 0.05 hence at 95%
confidence level we reject the null hypothesis and conclude that high school diploma and
higher is not a predictor of misusing prescription pain relievers among pregnant women
in the USA.
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Table 13
Binary Logistic Regression
95% C.I.for
EXP(B)
B

S.E.

Wald

Df

Sig.

Exp(B)

Lower

Upper

.039

.334

.014

1

.907

1.040

.540

2.001

.008

.439

Step

Education

1

Race

-2.806

1.012

7.691

1

.006

.060

Constant

-1.906

.310

37.872

1

.000

.149

a. Variable(s) entered on step 1: EDUHIGHCAT2, NEWRACE3.

All the six assumptions of using binary logistic regression were met as follows.
The dependent variable should be binary - use of pain-relievers when not directed by
doctor labeled PNRNMLIF was recoded as 1 and 2 with 1 representing those who
misused prescription pain relievers and 2 representing those who did not misuse
prescription pain relievers.
Since it assumes that P(Y-1) is the probability of the event occurring, the
dependent variable must be coded accordingly i.e., for a binary regression, the factor
level 1 of the dependent variable should represent the desired outcome. After the recode,
PNRNMLIF became PNRNMLIF2 and 1 represented yes/those who misused prescription
pain relievers.
Model fitting with only meaningful variables being included. The HosmerLemeshow test compares the observed and expected frequencies and assesses how well
the model fits. The p-value was higher than the chosen p-value (.940 vs .05) hence the

45
predicted probabilities were not deviating from the observed probabilities indicating a
good model fit.
No multicollinearity – from the multiple linear regressions ran, we got variance
inflation factors (VIFs) for pain reliever misuse as 1.007, for race as 1.000, and for
education as 1.020 (see appendix A). These were all below 4. According to PennState
Eberly College of Science (2018), VIFs exceeding 4 require further investigation and
VIFs exceeding 10 require correction due to serious multicollinearity.
The linearity of independent variables and log-odds. The dependent variable was
categorical and so were the independent variables. In this study, all the variables were
binary after the independent variables were transformed.
Requires large sample – NSDUH is a national survey and this study focused on all
women who were pregnant. After selecting the target group of pregnant women, a final
sample of 732 was used.
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Table 14
Summary of Findings
Variable

N

Percentage (%)

15 – 17

21

2.9

18 – 25

335

45.8

26 – 44

372

50.8

4

0.5

Non-African-American

623

85.1

African-American

109

14.9

Below high school

116

15.8

Above high school

616

84.2

Yes

84

11.5

No

648

88.5

Total

732

100

Age

Otherwise
Race

Education Level

Prescription pain reliever misuse

Summary
People who misuse prescription pain relievers may have varying characteristics
but based on the results from this study, race plays a significant role. Section 3 presented
the results and findings of my study on the misuse of prescription pain relievers by
pregnant women in the USA. Using data from the NSDUH of 2016, a secondary analysis
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was done to find out the associations race and education level (independent variables)
have with the misuse of prescription pain relievers (dependent variable) by pregnant
women. Detailed analysis and discussion of these findings will be discussed in the next
section, Chapter 4. Chapter 4 will elaborate on the findings and their interpretations, and
the significance or positive social impact of these findings will also be discussed. These
will be in alignment with the HBM model which guided this study. Recommendations
that will guide future studies will also be documented.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
This study aimed to investigate the misuse of prescription pain relievers by
pregnant women in the USA. Guided by two research questions, this cross-sectional
study was undertaken to understand the associations between misusing pain relievers and
social determinants of health especially education level and race in pregnant women
using secondary analysis of data from a countrywide survey (NSDUH 2016). Section 4
includes a summary and interpretation of the key findings, limitations of the study,
recommendations especially for future studies, implications for professional practice and
social change, and the conclusions.
Interpretation of Findings
In this section, findings are analyzed in alignment with the HBM model
portraying the social impact they have.
Table 15
Summary of Results by Research Question and Predictor (Pain Reliever Misuse)
Research question

Results

Is there an association between race and

African-American race decreases the odds

pain reliever misuse among pregnant

of misusing prescription pain relievers

women in the USA?

(change by a factor of 0.06)

Is there an association between education

Education level does not have an

level and pain reliever misuse among

association with pain reliever misuse.

pregnant women in the USA?
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Pain Relievers Misused
From this study, the most misused pain reliever was Hydrocodone followed by
Vicodin which contains Hydrocodone, Tylenol with Codeine 3 or 4, and Suboxone.
NIDA (2020) explains that Hydrocodone is the most prescribed prescription pain reliever
in the USA, and this could be a factor leading to it being the most misused as shown by
these findings. This can be viewed in terms of perceived barriers, but in this case, it is an
enabler since it is commonly prescribed hence leading to higher availability and
accessibility.
Pregnancy and Misuse of Pain Relievers
Pain is inevitable, and pregnant women experience it too. Management of pain in
pregnant women is a challenge due to possible effects these may have on the fetuses
(Black et al., 2019). Prescription of pain relievers including opioids for the management
of such pain occurs, and some end up misusing them. According to Dirks (2018), there
was a rise in the misuse of prescription pain relievers in the last 2 decades due to the
increased awareness of chronic pain by physicians. Dirks noted that an even more
distressing issue is that 99% of prescription hydrocodone produced is consumed by
Americans. Black et al. (2019) stated that the treatment of pain should be at the lowest
therapeutic dose and for the shortest duration possible, but with increased prescription
and the trust people have in their doctors, the feeling of euphoria may lead to misuse of
the drugs (Dirks, 2018).
To achieve target 3.5 of the SDG 3 and RWJF vision of ensuring healthy lives and
giving everyone an equal opportunity to good health regardless of their differences
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including race, targeting prevention strategies to those who are at higher risk, which the
findings from this study show to be the non-African-American race, will yield good
results. Krans and Patrick (2016) state that controlling the prescription of pain relievers to
protect mothers and infants should involve education and monitoring of prescribers. NonAfrican-American individuals are at a higher risk of misusing prescription pain relievers
among pregnant women. Targeting education messages to these women and their
prescribers will lead to good progress toward achieving the SDG goals and the vision of
the RWJF.
Collier (2020) explained that among the prescription pain relievers used in
pregnancy, opioids such as oxycodone and hydrocodone are prescribed for moderate to
severe pain. Prolonged and increased amounts used lead to consequences such as NAS,
premature deliveries, and poor fetal growth as well as the risk of stillbirths. These side
effects can be traumatizing to the family members. According to Dirks (2018), these
effects include those affecting the unborn fetus, and those that affect the people around
the misusers. Neglect and child abuse, both physical and emotional, have been listed as
some effects of misusing prescription pain relievers by pregnant women.
Limitations of the Study
Since this study was based on the NSDUH data which relied on self-reporting, the
respondents may have failed to report that they were pregnant or may have been unaware
of their pregnancy status at the time of the survey. Some may have reported that they
were pregnant when they were not. However, the use of self-report measures of
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pregnancy is considered to be a valid and reliable approach in epidemiological research,
as stated by Overbeek et al. (2013).
OTC pain relievers such as Tylenol, aspirin, Advil, and Aleve were excluded
from the list of prescription pain relievers in NSDUH, as stated by SAMHSA (2017).
According to Trottier et al. (2012), systemic non-opioid analgesics such as
acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs are used to treat pain
during pregnancy. CDC, (2019) lists Tylenol, aspirin, Advil, and Aleve as OTC
medicines used by pregnant women. These could also be prescribed by medics for use to
treat pain since not all medications are safe to use during pregnancy.
Recommendations
Pregnant women form a complex group to manage especially due to the unborn
fetuses that they are carrying. Black et al. (2019) in their study explained that because of
ethical concerns, safety information on drugs used during pregnancy is largely reliant on
animal data. This is true for pain relievers. According to Ray-Griffith et al. (2018), pain
management among pregnant women is left to the obstetricians. Pregnancy is also one
exclusion criteria for most pain programs as explained by Ray-Griffith et al. (2018), yet
they also experience pain. Studies and programs on pain management should include
mothers who have recently given birth for evidence-based strategies to be developed.
As noted by Black et al. (2019) and Ray-Griffith et al. (2018), pregnant women
are excluded in various studies, hence recommending further studies to be conducted to
understand the safety profile of these medications. Hydrocodone is highly misused; hence
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more studies need to be conducted to establish a better understanding of its safety with
race as a variable to focus on.
Implications for Professional Practice and Social Change
This study introduced African-American race as a factor that decreases the odds
of misusing prescription pain relievers among pregnant women. Pregnant women
surveyed during the NSDUH of 2016 formed the study population in this study hence the
findings are generalizable to them. Black et al. (2019) Ray-Griffith et al. (2018) reported
that pain management in pregnant women poses a challenge due to safety issues and this
leads to obstetricians being left with the task of managing their pain on their own.
Perceived susceptibility, which is one of the constructs of HBM, the model that
guided this study, is reflected by the findings in terms of African-American race being a
negative predictor of misusing prescription pain relievers among pregnant women.
Strategies to combat the misuse of prescription pain relievers by pregnant women can be
guided by this study’s findings since African-American race decreases the odds of
misusing the prescribed pain relievers. The non-African-American race can be targeted
by the strategies. Development of guidelines in pain management can be guided by this
meaning the obstetricians should consider race when making their prescriptions and
include in-depth education especially when it is inevitable to prescribe them. Ray-Griffith
et al. (2018) listed guidelines that can be a starting point in the discussion of pain
management among pregnant women including conducting thorough medical histories,
discussing other substance use such as alcohol, and involving the pregnant women in
establishing the treatment goals.
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NIDA (2020) stated that these prescription pain opioids require attention due to
the rising cases of NAS associated with the increasing prescriptions and deaths. The nonmedical use of prescription pain relievers can be addressed by involving prescribing
clinicians as well as the patients. According to NIDA (2020), more than 84% of
Americans had contact with healthcare professionals hence placing them in good
positions to identify potential misusers. This could be through tracking refills and any
frequent change in doctors. As these clinicians balance between those who will benefit
from the prescriptions and those who are just misusers, they are also expected to educate
them (NIDA, 2020).
Clear education on how to take the prescriptions in terms of the correct dosage,
potential drug interactions, and to never use other people’s prescriptions should be done.
Proper disposal of leftover and expired prescription pain relievers and giving honest
medical histories including what other prescriptions they may be taking is a role the
patients can take in curbing this increase (NIDA, 2020). With the non-African-American
race being at higher odds of misusing prescription pain relievers, clinicians should ensure
that these patients get all the education and counseling regarding their correct use.
Launched in August 2020, Healthy People 2030 (HP2030) maintained the
objective of reducing the non-medical use of prescription pain relievers which was in
Healthy People 2020 (HP2020). To achieve its mission of promoting, strengthening, and
evaluating the nation’s efforts to improve its people’s health and well-being, one plan of
action is to direct actions to specific groups HHS, n.d.). The department plans to use
evidence-based data and findings from this study from the pregnant women who misused
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prescription pain relievers, which will address this plan of action through guiding in the
development of strategies and targeted actions.
Comprehensive management of pregnant women especially concerning pain is a
vital subject. CDC (2020) noted that MAT in combination with counseling, and
behavioral therapies used to treat substance use disorders can lead to more favorable
outcomes. One major concern with the misuse of prescription pain relievers by pregnant
women is the effects it will have on the unborn child. NAS can be a consequence of using
MAT among pregnant women hence clinicians should discuss the benefits that outweigh
this. According to CDC (2020), providing families with plans of safe care is fundamental.
Pregnant women should also be screened for other mental health conditions.
Anxiety and depression have been listed to affect women who misuse prescription pain
relievers especially opioids (CDC, 2020). Screening for depression, anxiety, and other
mental health conditions should be done for all pregnant women especially those of the
non-African-American race and this should be done to include providing access or
referrals to appropriate psychosocial support as needed CDC, 2020).
Conclusion
The misuse of prescription pain relievers is a public health concern that needs
interventions and Bonnie et al. (2019) explained that with the increased recognition of
pain and its diagnosis, more physicians are prescribing pain relievers leading to an
increase in its accessibility and consequently its misuse. CDC (2018) and NIDA (2020)
listed hydrocodone as one of the most misused prescription pain relievers and this study
found that it was the most misused prescription pain reliever among pregnant women.
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Education level was not associated with the misuse of prescription pain relievers among
the pregnant women while race was. Non-African-American pregnant women were more
likely to misuse prescription pain relievers. Prevention and intervention programs
addressing the misuse of prescription pain relievers are necessary especially targeting
racial and ethnic groups.
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Appendix

Coefficientsa
Model
1

Education
Race
a. Dependent Variable: Pain reliever misuse

Collinearity Statistics
Tolerance
VIF
.993
1.007
.993
1.007

Coefficientsa
Model
1

Race
Pain reliever
misuse
a. Dependent Variable: Education

Collinearity Statistics
Tolerance
VIF
.981
1.020
.981
1.020

Coefficientsa
Model
1

Pain reliever
Education
a. Dependent Variable: Race

Collinearity Statistics
Tolerance
VIF
1.000
1.000
1.000
1.000

